Key result
Theophylline ethylenediamine demonstrated a dilating action on the coronary arteries in experimental dog models.
Early literature discussing the potential of theophylline and xanthine derivatives to dilate coronary arteries and act as diuretics in the treatment of coronary artery disease.
Animal data on coronary dilation warrant no practice change; leaves open human translation for xanthines in CAD.
The reduction in the coronary circulation through the gradual encroachment on the lumen due to sclerotic changes and, finally, the occlusion of vessels of varying size is primarily responsible for the cardiac disability in disease of the coronary arteries. It is thus important that treatment be directed toward the restoration and maintenance of an effective coronary circulation in this form of cardiac disease. Various remedies, particularly the xanthine derivatives, have been recommended for this purpose. In a previous communication1experimental data concerning the effectiveness of these preparations were reviewed, and additional observations relative to the dilating action of theophylline ethylenediamine were reported. The latter experiments in our opinion conclusively demonstrated the dilating action of this preparation on the coronary arteries of the dog. The xanthine derivatives are well known for their diuretic action, and it is generally conceded that theophylline is the most effective of the group. Marvin2
No takes yet. Share an insight, caveat, or question.
FRED M. SMITH (1935) conducted a review in disease of the coronary arteries. Theophylline was evaluated. Theophylline ethylenediamine demonstrated a dilating action on the coronary arteries in experimental dog models.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: